Home NDC 65597-202 SAVAYSA
Product NDC 65597-202
11-digit product format 655970202
Labeler code 65597
Product ID 65597-202_dc54247c-0158-4cae-b692-914717ab3a67
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name EDOXABAN TOSYLATE
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Daiichi Sankyo Inc.
Application NDA206316
Marketing category NDA
Marketing start 2015-01-12
Substance EDOXABAN TOSYLATE
Active strength 30 mg/1
Pharmacologic classes Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206316-001 SAVAYSA EDOXABAN TOSYLATE EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 N206316-002 SAVAYSA EDOXABAN TOSYLATE EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 N206316-003 SAVAYSA EDOXABAN TOSYLATE EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 N206316-003 9149532 2028-03-28 Drug product 2015-12-17
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N206316-001 M-14 2026-10-18 N206316-002 M-14 2026-10-18 N206316-003 M-14 2026-10-18
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206316-002 SAVAYSA EQ 30MG BASE TABLET / ORAL RLD 2015-01-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206316-003 SAVAYSA EQ 60MG BASE TABLET / ORAL RLD, RS 2015-01-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206316-001 SAVAYSA EQ 15MG BASE TABLET / ORAL RLD 2015-01-08 301d65b070ca…
Observed Orange Book patent history# Patent history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-003 7365205 2027-04-18 Drug substance 2015-01-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206316-003 9149532 2028-03-28 Drug product 2015-12-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-001 7365205 2027-04-18 Drug substance 2015-01-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-001 9149532 2028-03-28 Drug product 2015-12-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-002 7365205 2027-04-18 Drug substance 2015-01-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206316-002 9149532 2028-03-28 Drug product 2015-12-17 b8a1b40f171c…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 126 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base SAVAYSA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength EDOXABAN TOSYLATE 30 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 32W99UE810 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1599543 Internal RxNorm lookup 1599549 Internal RxNorm lookup 1599551 Internal RxNorm lookup 1599553 Internal RxNorm lookup 1599555 Internal RxNorm lookup 1599557 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 65597-202-05 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-07 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-10 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-30 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-50 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-70 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-90 2024-02-06 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-05 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-07 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-10 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-30 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-50 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-70 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015 65597-202-90 2024-01-30 These highlights do not include all the information needed to use SAVAYSA safely and effectively. See full prescribing information for SAVAYSA. SAVAYSA ® (edoxaban) tablets, for oral use Initial U.S. Approval: 2015
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65597-202-05 SAVAYSA 50 in 1 CARTON TABLET, FILM COATED 50 28 65597-202-05 SAVAYSA 1 in 1 BLISTER PACK TABLET, FILM COATED 1 28 65597-202-07 SAVAYSA 7 in 1 BOTTLE TABLET, FILM COATED 7 28 65597-202-10 SAVAYSA 1 in 1 BLISTER PACK TABLET, FILM COATED 1 28 65597-202-10 SAVAYSA 100 in 1 CARTON TABLET, FILM COATED 100 28 65597-202-30 SAVAYSA 30 in 1 BOTTLE TABLET, FILM COATED 30 28 65597-202-50 SAVAYSA 500 in 1 BOTTLE TABLET, FILM COATED 500 28 65597-202-70 SAVAYSA 7 in 1 BLISTER PACK TABLET, FILM COATED 7 28 65597-202-90 SAVAYSA 90 in 1 BOTTLE TABLET, FILM COATED 90 28
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65597-202 SAVAYSA (EDOXABAN TOSYLATE) TABLET, FILM COATED [DAIICHI SANKYO INC.] 26 Current NDC, Legacy NDC, 9 package rows 20240207_e77d3400-56ad-11e3-949a-0800200c9a66.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join SAVAYSA EDOXABAN TOSYLATE Daiichi Sankyo Inc. e77d3400-56ad-11e3-949a-0800200c9a66 2025-07-10 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 206316 application number: NDA206316 ndc (product): 65597-202
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 65597-202-05 65597020205 50 BLISTER PACK in 1 CARTON (65597-202-05) / 1 TABLET, FILM COATED in 1 BLISTER PACK 50 blister pack 2015-01-31 0000-00-00 No No Current 65597-202-07 65597020207 7 TABLET, FILM COATED in 1 BOTTLE (65597-202-07) 2015-01-31 0000-00-00 No No Current 65597-202-10 65597020210 100 BLISTER PACK in 1 CARTON (65597-202-10) / 1 TABLET, FILM COATED in 1 BLISTER PACK 100 blister pack 2015-01-31 0000-00-00 No No Current 65597-202-30 65597020230 30 TABLET, FILM COATED in 1 BOTTLE (65597-202-30) 2015-01-31 0000-00-00 No No Current 65597-202-50 65597020250 500 TABLET, FILM COATED in 1 BOTTLE (65597-202-50) 2015-01-31 0000-00-00 No No Current 65597-202-70 65597020270 7 TABLET, FILM COATED in 1 BLISTER PACK (65597-202-70) 2015-01-31 0000-00-00 No No Current 65597-202-90 65597020290 90 TABLET, FILM COATED in 1 BOTTLE (65597-202-90) 2015-01-31 0000-00-00 No No Current